ANI Pharma Acquires Vancocin Capsules, Additional Vancomycin Assets From Shire

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) said Friday that it has acquired the US rights for Vancocin 125 mg and 250 mg capsules from Shire plc.

In addition, ANI acquired from Shire approved ANDAs for the currently non-marketed products vancomycin hydrochloride injectable 500 mg, 1 gm and 10 gm and vancomycin hydrochloride oral solution 250 mg and 500 mg.

ANI paid $11 million in cash for the rights to Vancocin together with existing inventories on hand. Following a transition period, ANI plans to launch Vancocin capsules under its own label during the fourth quarter of 2014.

The deal is immediately accretive and sales of Vancocin capsules are expected to generate about $5.4 million in revenues annually.